One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model. / Rai, Akhilesh; Pinto, Sandra; Velho, Tiago R; Ferreira, André F; Moita, Catarina; Trivedi, Urvish; Evangelista, Marta; Comune, Michela; Rumbaugh, Kendra P.; Simões, Pedro N; Moita, Luís; Ferreira, Lino.
I: Biomaterials, Bind 85, 2016, s. 99-110.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model
AU - Rai, Akhilesh
AU - Pinto, Sandra
AU - Velho, Tiago R
AU - Ferreira, André F
AU - Moita, Catarina
AU - Trivedi, Urvish
AU - Evangelista, Marta
AU - Comune, Michela
AU - Rumbaugh, Kendra P.
AU - Simões, Pedro N
AU - Moita, Luís
AU - Ferreira, Lino
N1 - Copyright © 2016 Elsevier Ltd. All rights reserved.
PY - 2016
Y1 - 2016
N2 - The increase in antibiotic drug resistance and the low number of new antibacterial drugs approved in the last few decades requires the development of new antimicrobial strategies. Antimicrobial peptides (AMPs) are very promising molecules to fight microbial infection since they kill quickly bacteria and, in some cases, target bacterial membrane. Although some AMPs may be stable against proteolytic degradation by chemical modification, in general, low AMP activity and stability in the presence of serum and proteolytic enzymes as well as their cytotoxicity have impaired their clinical translation. Here, we describe a one-step methodology to generate AMP-conjugated gold nanoparticles (Au NPs), with a high concentration of AMPs (CM-SH) (≈240 AMPs per NP), controlled size (14 nm) and low polydispersity. AMP-conjugated Au NPs demonstrated higher antimicrobial activity and stability in serum and in the presence of non-physiological concentrations of proteolytic enzymes than soluble AMP, as well as low cytotoxicity against human cells. Moreover, the NPs demonstrated high antimicrobial activity after in vivo administration in a chronic wound and in an animal model of systemic infection.
AB - The increase in antibiotic drug resistance and the low number of new antibacterial drugs approved in the last few decades requires the development of new antimicrobial strategies. Antimicrobial peptides (AMPs) are very promising molecules to fight microbial infection since they kill quickly bacteria and, in some cases, target bacterial membrane. Although some AMPs may be stable against proteolytic degradation by chemical modification, in general, low AMP activity and stability in the presence of serum and proteolytic enzymes as well as their cytotoxicity have impaired their clinical translation. Here, we describe a one-step methodology to generate AMP-conjugated gold nanoparticles (Au NPs), with a high concentration of AMPs (CM-SH) (≈240 AMPs per NP), controlled size (14 nm) and low polydispersity. AMP-conjugated Au NPs demonstrated higher antimicrobial activity and stability in serum and in the presence of non-physiological concentrations of proteolytic enzymes than soluble AMP, as well as low cytotoxicity against human cells. Moreover, the NPs demonstrated high antimicrobial activity after in vivo administration in a chronic wound and in an animal model of systemic infection.
KW - Animals
KW - Anti-Infective Agents/chemistry
KW - Antimicrobial Cationic Peptides/chemistry
KW - Cells, Cultured
KW - Disease Models, Animal
KW - Dose-Response Relationship, Drug
KW - Escherichia coli/drug effects
KW - Gold/chemistry
KW - Humans
KW - Klebsiella pneumoniae/drug effects
KW - Metal Nanoparticles/chemistry
KW - Mice
KW - Mice, Inbred C57BL
KW - Peripheral Blood Stem Cells/drug effects
KW - Pseudomonas aeruginosa/drug effects
KW - Staphylococcus aureus/drug effects
U2 - 10.1016/j.biomaterials.2016.01.051
DO - 10.1016/j.biomaterials.2016.01.051
M3 - Journal article
C2 - 26866877
VL - 85
SP - 99
EP - 110
JO - Biomaterials
JF - Biomaterials
SN - 0142-9612
ER -
ID: 215364562